Effect of rifampin and itraconazole on the pharmacokinetics of zanubrutinib (a Bruton's tyrosine kinase inhibitor) in Asian and non-Asian healthy subjects

por Mu, Song, Tang, Zhiyu, Novotny, William, Tawashi, Manal, Li, Ta-Kai, Ou, Ying, Sahasranaman, Srikumar
Publicado 2019

Evaluation of drug interaction potential of zanubrutinib with cocktail probes representative of CYP3A4, CYP2C9, CYP2C19, P‐gp and BCRP

por Ou, Ying C., Tang, Zhiyu, Novotny, William, Tawashi, Manal, Li, Ta‐Kai, Coleman, Hugh A., Sahasranaman, Srikumar
Publicado 2021

Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein

por Owsianka, Ania M., Tarr, Alexander W., Keck, Zhen-Yong, Li, Ta-Kai, Witteveldt, Jeroen, Adair, Richard, Foung, Steven K. H., Ball, Jonathan K., Patel, Arvind H.
Publicado 2008